Fresenius | FRE - Current Liabilities

Stock Price
48.60
Daily Change
0.64 1.32%
Monthly
1.90%
Yearly
31.62%
Q1 Forecast
45.82

Fresenius reported EUR9.56B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.84B 326M Sep/2025
Alcon AG USD 2.99B 566M Sep/2025
AstraZeneca USD 34.05B 518M Sep/2025
BASF EUR 17.25B 932M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Beiersdorf EUR 3.77B 6.12B Jun/2025
DaVita Healthcare Partners USD 3.02B 83.59M Sep/2025
Demant DKK 5.79B 301M Jun/2025
E.ON EUR 25.63B 2.46B Sep/2025
Essilor EUR 11.39B 832M Jun/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 5.76B 98.85M Sep/2025
Getinge SEK 15.05B 169M Dec/2024
Givaudan CHF 2.97B 911M Jun/2024
GlaxoSmithKline GBP 21.33B 956M Sep/2025
GN Store Nord DKK 7.47B 420M Sep/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 8.64B 1.22B Sep/2025
Novartis USD 32B 286M Sep/2025
Philips EUR 7.03B 171M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
RWE EUR 20.3B 3.14B Sep/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025